Hopp til hovedinnhold

Akutt koronarsyndrom

Akutt koronarsyndrom er betegnelsen på akutt oppståtte brystsmerter som skyldes forsnevring av en eller flere av hjertets koronararterier, og som uten snarlig behandling kan føre til hjerteinfarkt.

Sist revidert:

QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/hjertekar/koronarsykdom/akutt-koronarsyndrom/ 

Hva er akutt koronarsyndrom?

Årsaker

Diagnostikk

Behandling

Prognose

Vil du vite mer?

Animasjoner

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Akutt koronarsyndrom. Referanselisten for dette dokumentet vises nedenfor.

  1. Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2020. pmid:32860058 PubMed 
  2. Kolte D, Libby P, Jang I-K. New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes. JAMA 2021. pmid:33616637 PubMed 
  3. Karha J, Murphy SA, Kirtane AJ et al, for the TIMI study group. Evaluation of the association of proximal coronary culprit artery location with clinical outcomes in acute myocardial infarction. Am J Cardiol 2003; 92: 913-8. PubMed 
  4. Elsman P, van`t Hof AWJ, Hoorntje JCA et al. Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention. Am J Cardiol 2006; 97: 1137-41. PubMed 
  5. Amsterdam EA, Wenger NK, Brindis RG, et al. AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 130: e344-426. PMID: 25249585 PubMed 
  6. Thygesen K , Alpert JS , Jaffe AS , Chaitman BR , Bax JJ , Morrow DA , White HD , ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019;40:237–269. PMID: 30154043 PubMed 
  7. Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathi. N Engl J Med 2015; 373: 929-38. New England Journal of Medicine 
  8. Goodacre S, Locker T, Morris F, Campbell S. How useful are clinical features in the diagnosis of acute, undifferentiated chest pain? Acad Emerg Med 2002; 9: 203-8. PubMed 
  9. Feldman JA, Fish SS, Beshansky JR, Griffith JL, Woolard RH, Selker HP. Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial. Ann Emerg Med 2000; 36: 469-76. PubMed 
  10. Fanaroff AC, Rymer JA, Goldstein SA, et al. Does this patient with chest pain have acute coronary syndrome? The rational clinical examination. Systematic review. N Engl J Med 2015; 314: 1955-65. PMID: 26547467 PubMed 
  11. Forselv GC, Vik-Mo H. EKG-forandringer ved akutt koronarsyndrom uten ST-elevasjon. Tidsskr Nor Lægeforen 2007; 127: 2230-2. PubMed 
  12. Pope JH, Selker HP. Diagnosis of acute cardiac ischemia. Emerg Med Clin North Am 2003; 21: 27-59. PubMed 
  13. Serum marker analysis in acute myocardial infarction. American College of Emergency Physicians. Ann Emerg Med 2000; 35: 534-9. PubMed 
  14. Moss AJ, Newby DE. CT coronary angiographic evaluation of suspected anginal chest pain. Heart 2015. doi:10.1136/heartjnl-2015-307860 DOI 
  15. Williams MC, Hunter A, Shah AS, et al. Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease. J AM Coll Cardiol 2016; 67: 1759-68. pmid:27081014 PubMed 
  16. Coughlan JJ, Aytekin A, Lahu S, et al. Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention A Prespecified Subgroup Analysis of a Randomized Clinical Trial. JAMA Cardiol 2021. pmid:34190967 PubMed 
  17. Kim B-K, Hong S-J, Cho Y-H, et al. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome The TICO Randomized Clinical Trial. JAMA 2020; 323: 2407-16. doi:10.1001/jama.2020.7580 DOI 
  18. Kamran H, Jneid H, Kayani WT, et al. Oral Antiplatelet Therapy After Acute Coronary Syndrome A Review. JAMA 2021; 325: 1545-55. pmid:33877270 PubMed 
  19. Ray K, Colhoun H, Szarek M, et al. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol 2019. pmid:31272931 PubMed 
  20. Sinnaeve PR, Schwartz GG, Wojdyla DM, et al. Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis. Eur Heart J. 2019. PMID: 31732742 PubMed 
  21. Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med 2020. pmid:32865380 PubMed 
  22. Tong DC, Quinn S, Nasis A, et al. Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial. Circulation 2020. pmid:32862667 PubMed 
  23. Mehta SR, Tanguay J-F, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010; : DOI:10.1016/S0140-6736(10)61088-4. DOI